Hackensack Meridian Health Oncology

Hackensack Meridian Health Among First Hospitals to Provide BgRT Treatment Opening a New Option for Stage IV Cancer

John Theurer Cancer Center 6th Site in the World to Adopt RefleXion®X1 Precision Radiation Treatment

Genetic Tie to Cancer and Treatment-Related Cognitive Decline for Older Breast Cancer Survivors

Hackensack University Medical Center participates in study identifying two SNPs with potential cognition impact

Researchers at John Theurer Cancer Center at Hackensack University Medical Center Help Develop New Liquid Biopsy Technique

Approach combines cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors

ZUMA-1 Five-Year Follow-Up Shows Axicabtagene Ciloleucel Treatment Success for Refractory Large B-Cell Lymphoma

John Theurer Cancer Center at Hackensack University Medical Center researchers assess outcomes for aggressive B-cell lymphoma treatment

John Theurer Cancer Center at Hackensack University Medical Center Study Tracks Long-Term Survival With First-Line Nivolumab Plus Ipilimumab in Patients With Advanced Non-Small-Cell Lung Cancer

Pooled analysis deepens clinical benefit knowledge and assesses survival impact

Improved Survival for B-NHL With Fludarabine Exposure Target Window Identified in John Theurer Cancer Center at Hackensack University Medical Center Research

Negative effects of Flu over and underexposure found common with body-surface areas based dosing in study presented at ASH annual meeting